In this regard, most studies look at berberines effects on nonalcoholic fatty liver disease, but inflammation is also a critical part of conditions like heart disease and diabetes.12 17 Notably, a 2020 meta-analysis found significant reductions in CRP (C-reactive protein, a major marker of inflammation) in patients taking berberine.18 A 2024 review of randomized controlled trials corroborated the findings of the 2020 meta-analysis.53 For diabetes care One of the few things we can almost conclusively say berberine supports is diabetic care
Powe DG, Akhtar G, Habashy HO, Abdel-Fatah T, Rakha EA, Green AR, Ellis IO
Lets use a common scenario: you have a 5mg vial of BPC 157 and a 5mg vial of TB 500
Biochem Pharmacol , 75: 22342244, 2008
Ortega A, Ferrer P, Carretero J, Obrador E, Asensi M, Pellicer JA, and Estrela JM
Similarly, CAR activation upregulates enzymes like CYP2B6 and transporters that contribute to the elimination of bilirubin and bile acid metabolites